Enable Injections, a company developing and manufacturing the enFuse platform of investigational wearable drug delivery systems, has announced $215 million in Series C financing.

Magnetar Capital led the financing along with new institutional investments from GCM Grosvenor, Squarepoint Capital, Woody Creek Capital Partners, and other investors. Enable received significant continued support from existing investors including Cincinnati Children's Hospital Medical Center, CincyTech, Cintrifuse, and Ohio Innovation Fund.